EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems

Xiaoyuan Ye iD, Nicholas Siu Kay Fung, Wai Ching Lam, Amy Cheuk Yin Lo iD

Nutrients · 30.05.2024 · 16 (11) · 1715

DOI: 10.3390/nu16111715 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 30.05.2024. Verfasst von Xiaoyuan Ye und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The University of Hong Kong, Hong Kong 999077, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Dietary Supplements. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Health and Medical Research Fund, the Food and Health Bureau, The Government of the Hong Kong Special Administration Region of China, General Research Fund, Research Grants Council, The Government of the Hong Kong Special Administrative Region.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic retinopathy (DR) is a major vision-threatening disease among the working-age population worldwide. Present therapeutic strategies such as intravitreal injection of anti-VEGF and laser photocoagulation mainly target proliferative DR. However, there is a need for early effective management in patients with early stage of DR before its progression into the more severe sight-threatening proliferative stage. Nutraceuticals, natural functional foods with few side effects, have been proposed to be beneficial in patients with DR. Over the decades, many studies, either in vitro or in vivo, have demonstrated the advantages of a number of nutraceuticals in DR with their antioxidative, anti-inflammatory, neuroprotective, or vasoprotective effects. However, only a few clinical trials have been conducted, and their outcomes varied. The low bioavailability and instability of many nutraceuticals have indeed hindered their utilization in clinical use. In this context, nanoparticle carriers have been developed to deliver nutraceuticals and to improve their bioavailability. Despite its preclinical nature, research of interventive nutraceuticals for DR may yield promising information in their clinical applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyDietary SupplementsHumansAntioxidantsBiological AvailabilityDrug Delivery SystemsAnimalsAnti-Inflammatory Agents

Stichwörter der Autor:innen

blindnessdiabetesdietary supplementinflammationnanotechnologynatural productneovascularizationoxidative stressretinavessel

Substanzen

AntioxidantsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Ophthalmology, The University of Hong Kong, Hong Kong 999077, China.
  • Department of Ophthalmology, University of British Columbia, 2550 Willow Street, Room 301, Vancouver, BC V5Z 3N9, Canada.

ORCID-Profile: Xiaoyuan Ye, Amy Cheuk Yin Lo

Förderung

  • The Health and Medical Research Fund, the Food and Health Bureau, The Government of the Hong Kong Special Administration Region of China
  • General Research Fund, Research Grants Council, The Government of the Hong Kong Special Administrative Region

Zitieren

APA

Ye, X., Fung, N. S. K., Lam, W. C., & Lo, A. C. Y. (2024). Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems. Nutrients, 16(11), 1715. https://doi.org/10.3390/nu16111715

Vancouver

Ye X, Fung NSK, Lam WC, Lo ACY. Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems. Nutrients. 2024;16(11):1715. doi:10.3390/nu16111715

BibTeX
@article{Ye2024,
  author = {Ye, Xiaoyuan and Fung, Nicholas Siu Kay and Lam, Wai Ching and Lo, Amy Cheuk Yin},
  title = {Nutraceuticals for Diabetic Retinopathy: Recent Advances and Novel Delivery Systems},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {11},
  pages = {1715},
  doi = {10.3390/nu16111715}
}
Kostenlos starten →